Funding for this research was provided by:
Fogarty International Center (D43TW006578)
National Research Foundation (GUN86037, GUN109312)
South African Medical Research Council (RCDI 57009)
Myles H. Thaler Center for HIV and Human Retrovirus Research (University of Virginia Endowment)
Received: 2 July 2018
Accepted: 21 December 2018
First Online: 19 January 2019
Ethics approval and consent to participate
: The study protocol was approved by the Research Ethics Committee of the University of Venda (SMNS/13/MBY/01/0625) and the University of Virginia Institutional Review Board (IRB-HSR #16815). Permission to access public sector health facilities was obtained from the Limpopo Provincial Department of Health, South Africa. Written informed consent was obtained from all study participants prior to demographic and clinical data collection, and blood draw. Written consent was obtained from a parent or guardian on behalf of participants under the age of 16.
: Personal identifiers were stripped prior to sample processing and data analysis, so a request for consent is non-applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.